Semaglutide 1mg: where does this dose fit in your weight-loss journey?

Why the titration schedule exists, and where 1mg sits in it

Semaglutide works by acting on GLP-1 receptors involved in appetite regulation and the rate at which your stomach empties. That second mechanism (slowing gastric emptying) is also the main driver of early nausea and digestive discomfort. Starting at a high dose would cause most people significant GI upset, so the prescribing schedule builds up gradually, giving the body time to adjust at each level.

The standard Wegovy injection schedule runs: 0.25mg for four weeks, then 0.5mg, then 1.0mg, then 1.7mg, arriving at the 2.4mg maintenance dose after roughly sixteen weeks of gradual increase. The full semaglutide dosing schedule explains each step in context. At 1mg you are still in a transitional phase, not yet at the doses where the majority of clinical weight loss tends to occur. That is normal, not a sign that treatment is not working.

The NHS medicines page for semaglutide confirms the step-wise titration approach and notes that dose changes should always follow your prescriber's direction. Never adjust your dose or timing without first speaking to the clinician managing your care.

The clinical gap between 1mg and the weight-management doses

It is worth understanding why 1mg is not, on its own, a weight-management dose for most people. The pivotal STEP 1 trial, published in the New England Journal of Medicine, tested semaglutide at 2.4mg and found an average weight reduction of around 15% over 68 weeks alongside lifestyle changes. The therapeutic effect scales with dose, and the bulk of that reduction comes at 1.7mg and 2.4mg.

The 1mg figure is more familiar from Ozempic, which uses that strength for blood glucose control in type 2 diabetes. Ozempic and Wegovy both contain semaglutide, but they carry separate UK licences for different conditions; Ozempic is not licensed for weight management. If you have seen references to semaglutide 1mg in a diabetes context, that is the likely source. For weight management, the clinical target is higher, and you can read about how 3mg semaglutide fits into higher-dose treatment to understand where the schedule is ultimately heading. A look at how maintenance dosing works for semaglutide may help set clearer expectations for where the schedule is heading.

If side effects at 1mg are difficult, the right step is to contact your prescriber, not to delay the increase indefinitely on your own. Staying at a sub-therapeutic dose for longer than intended is not clinically neutral.

What to expect at this stage of the schedule

By the time most people reach 1mg they have already had around eight weeks on the medicine. Many find that the nausea present in the first few weeks has begun to ease, though some GI symptoms can return briefly when a dose increases. The most commonly reported side effects across the semaglutide schedule are nausea, loose stools, constipation, indigestion and fatigue, usually most noticeable in the first few days after each dose change, then settling. The overview of Wegovy dose stages covers what tends to happen at each level.

Protein intake, hydration and eating smaller, lower-fat meals can all help manage tolerability at this stage. If symptoms feel more than mild or do not settle, speak to your prescriber or our aftercare team. Severe, persistent stomach pain that moves towards the back is a symptom that needs urgent medical attention rather than a call to us, seek emergency care if that occurs, in line with MHRA guidance on GLP-1 medicines.

Thinking about what comes next

If you are on 1mg and wondering whether you are ready to move to 1.7mg, that conversation belongs with your prescriber. A clinical review before any dose increase is standard at nume, it is not a formality; it is the check that ensures the next step is right for you specifically. Evidence of tolerability and any relevant health changes are part of that review.

If you have not yet started treatment and you are researching the schedule before deciding whether Wegovy is right for you, there is a broader comparison of weight-loss treatment options that may be useful. The route into treatment at a regulated pharmacy requires a full consultation with a prescriber, who will assess your medical history, current health and goals before recommending anything. When you feel ready, starting your free consultation with our clinical team takes a few minutes and is reviewed the same day by a GPhC-registered prescriber.